1. Home
  2. VALN vs MAX Comparison

VALN vs MAX Comparison

Compare VALN & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$11.30

Market Cap

875.7M

Sector

Health Care

ML Signal

N/A

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

N/A

Current Price

$9.63

Market Cap

722.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VALN
MAX
Founded
2012
2014
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
875.7M
722.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
VALN
MAX
Price
$11.30
$9.63
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$15.75
$14.58
AVG Volume (30 Days)
17.1K
1.2M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.81
EPS
N/A
0.39
Revenue
N/A
$1,113,600,000.00
Revenue This Year
$2.58
$10.18
Revenue Next Year
$4.43
$10.51
P/E Ratio
N/A
$25.82
Revenue Growth
N/A
28.78
52 Week Low
$5.43
$7.09
52 Week High
$12.25
$13.92

Technical Indicators

Market Signals
Indicator
VALN
MAX
Relative Strength Index (RSI) 57.93 50.63
Support Level $8.37 $7.09
Resistance Level $12.22 $11.20
Average True Range (ATR) 0.42 0.52
MACD -0.05 0.22
Stochastic Oscillator 59.63 71.94

Price Performance

Historical Comparison
VALN
MAX

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: